Cargando…

GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION

Geranylgeranylacetone (GGA) was originally used as an anti-ulcer drug to protect gastric mucosa from various stresses, and it is also known to induce heat shock proteins (HSPs), especially HSP70. However, it remains unclear how GGA affects cellular functions in the presence of anti-cancer drugs. We...

Descripción completa

Detalles Bibliográficos
Autores principales: HASEGAWA, MOTOFUSA, ISHIGURO, KAZUHIRO, ANDO, TAKAFUMI, GOTO, HIDEMI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831257/
https://www.ncbi.nlm.nih.gov/pubmed/22515118
_version_ 1782427037468721152
author HASEGAWA, MOTOFUSA
ISHIGURO, KAZUHIRO
ANDO, TAKAFUMI
GOTO, HIDEMI
author_facet HASEGAWA, MOTOFUSA
ISHIGURO, KAZUHIRO
ANDO, TAKAFUMI
GOTO, HIDEMI
author_sort HASEGAWA, MOTOFUSA
collection PubMed
description Geranylgeranylacetone (GGA) was originally used as an anti-ulcer drug to protect gastric mucosa from various stresses, and it is also known to induce heat shock proteins (HSPs), especially HSP70. However, it remains unclear how GGA affects cellular functions in the presence of anti-cancer drugs. We investigated the effects of GGA on cellular viability, caspase-3 activation, HSP induction and p53 content in the presence of cisplatin (CDDP). Rat intestinal epithelium-derived IEC-18 cells and human colon cancer-derived CW-2 cells were incubated with GGA in the presence of CDDP, and we observed that GGA attenuated CDDP-induced viability reductions. GGA also suppressed CDDP-induced caspase-3 activation. However, GGA induced neither HSP70 nor GRP78 expression in the presence of CDDP. We found that GGA suppressed the CDDP-induced elevation of intracellular p53 content. In conclusion, GGA attenuates viability reductions and caspase-3 activation in CDDP-treated cells by suppressing the elevation of intracellular p53 content without HSP induction.
format Online
Article
Text
id pubmed-4831257
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nagoya University
record_format MEDLINE/PubMed
spelling pubmed-48312572016-04-25 GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION HASEGAWA, MOTOFUSA ISHIGURO, KAZUHIRO ANDO, TAKAFUMI GOTO, HIDEMI Nagoya J Med Sci Original Paper Geranylgeranylacetone (GGA) was originally used as an anti-ulcer drug to protect gastric mucosa from various stresses, and it is also known to induce heat shock proteins (HSPs), especially HSP70. However, it remains unclear how GGA affects cellular functions in the presence of anti-cancer drugs. We investigated the effects of GGA on cellular viability, caspase-3 activation, HSP induction and p53 content in the presence of cisplatin (CDDP). Rat intestinal epithelium-derived IEC-18 cells and human colon cancer-derived CW-2 cells were incubated with GGA in the presence of CDDP, and we observed that GGA attenuated CDDP-induced viability reductions. GGA also suppressed CDDP-induced caspase-3 activation. However, GGA induced neither HSP70 nor GRP78 expression in the presence of CDDP. We found that GGA suppressed the CDDP-induced elevation of intracellular p53 content. In conclusion, GGA attenuates viability reductions and caspase-3 activation in CDDP-treated cells by suppressing the elevation of intracellular p53 content without HSP induction. Nagoya University 2012-02 /pmc/articles/PMC4831257/ /pubmed/22515118 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Paper
HASEGAWA, MOTOFUSA
ISHIGURO, KAZUHIRO
ANDO, TAKAFUMI
GOTO, HIDEMI
GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
title GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
title_full GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
title_fullStr GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
title_full_unstemmed GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
title_short GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
title_sort geranylgeranylacetone attenuates cisplatin-induced reductions in cell viability by suppressing the elevation of intracellular p53 content without heat shock protein induction
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831257/
https://www.ncbi.nlm.nih.gov/pubmed/22515118
work_keys_str_mv AT hasegawamotofusa geranylgeranylacetoneattenuatescisplatininducedreductionsincellviabilitybysuppressingtheelevationofintracellularp53contentwithoutheatshockproteininduction
AT ishigurokazuhiro geranylgeranylacetoneattenuatescisplatininducedreductionsincellviabilitybysuppressingtheelevationofintracellularp53contentwithoutheatshockproteininduction
AT andotakafumi geranylgeranylacetoneattenuatescisplatininducedreductionsincellviabilitybysuppressingtheelevationofintracellularp53contentwithoutheatshockproteininduction
AT gotohidemi geranylgeranylacetoneattenuatescisplatininducedreductionsincellviabilitybysuppressingtheelevationofintracellularp53contentwithoutheatshockproteininduction